EBOO Therapy: Vascular Rejuvenation Therapy After COVID-19 Vaccination

Although COVID-19 vaccines play a key role in reducing severe illness and death rates, there are concerns about certain side effects. One of these is thrombosis (blood clots) in combination with thrombocytopenia (low blood platelets), a condition caused by platelet clumping that results in abnormal blood flow. Medical studies have found that viral vector vaccines using adenovirus as a carrier, such as AstraZeneca and Johnson & Johnson, may be associated with vaccine-induced immune thrombotic thrombocytopenia (VITT). However, this condition is extremely rare but highly severe. Data shows that the incidence rate of VITT is approximately 1 in 26,500 to 1 in 518,181 individuals who received the AstraZeneca vaccine, and 1 in 263,000 individuals who received the Johnson & Johnson vaccine (Allas, Arizala, & Manalo, 2022). For mRNA vaccines like Pfizer and Moderna, there are no reports of them directly causing blood clots. Nevertheless, reports from the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) state that the benefits of COVID-19 vaccination in preventing infection and reducing disease severity still outweigh the potential risks of side effects.

According to the research mentioned above, patients diagnosed with VITT usually develop abnormal symptoms within 4 to 28 days, and symptoms can last up to 30 days after receiving the vaccine. Patients may initially experience symptoms starting with a fever and minor bruising. If there is a blood clot in the brain, it may cause dizziness, blurred vision, nausea, vomiting, or weakness in the arms and legs. If there is a blood clot in the abdomen, it can cause severe abdominal pain, nausea, and bloody stools. Therefore, those who receive a COVID-19 vaccine, especially during the first 1 to 30 days post-vaccination, should continuously monitor their symptoms and promptly consult a doctor for a detailed diagnosis if any abnormal symptoms occur.

EBOO Therapy (Extracorporeal Blood Oxygenation and Ozonation) is a therapy that combines the infusion of pure ozone into blood outside the body and then returns the treated blood back into the body through a vein. This process helps stimulate the function of blood cells, the immune system, and various tissue cells to return to their full efficiency. The key working principles of EBOO Therapy are as follows:

• Increasing Blood Circulation: EBOO Therapy helps improve blood circulation and increases oxygen delivery to various tissues, which benefits the vascular system.
• Helping Reduce Vascular Inflammation: Ozone therapy has anti-inflammatory properties that help reduce swelling, pain, and redness caused by inflammation, thereby benefiting blood vessel health.
• EBOO Therapy uses oxygen and ozone to purify the blood, which may help stimulate antioxidant processes in the body, helping to prevent cellular damage and reduce the risk of vascular diseases.

EBOO Therapy is a treatment process that helps infuse oxygen and ozone into the blood, while assisting in the removal of impurities from blood vessels, which has a positive effect on the blood circulation system and helps reduce inflammation. However, EBOO Therapy is not a direct cure or preventive method for thrombosis (blood clots). Instead, it serves as a supportive option suitable for those wishing to restore the function of their circulatory system, including individuals who have previously received a COVID-19 vaccine. In any case, undergoing EBOO Therapy should be done under the guidance of a specialized physician to evaluate suitability and safety based on each individual's health conditions.

For safety and optimal effectiveness after EBOO Therapy, interested individuals should consider and follow these recommendations:

• Groups that should exercise caution or avoid undergoing EBOO Therapy include pregnant women, individuals with blood clotting disorders (who must inform the physician of their detailed medical history), and those with ozone allergies. Furthermore, anyone interested in receiving the service should consult a physician and undergo a thorough physical evaluation to assess risks before starting therapy.
• Choose to undergo EBOO Therapy with a reputable clinic that utilizes standard EBOO equipment from leading countries, which can stably and precisely control the rate of ozone introduced into the body to ensure the therapy process is highly effective and safe.
• The treating physician must be a specialist with high experience. This is because the effectiveness of the therapy depends not only on the quality of the EBOO machine, but also on the physician's expertise and experience in the physical assessment process, treatment planning (such as setting the appropriate gas rate and ozone concentration), and closely monitoring the balance of blood inflow and outflow during the treatment to ensure the safety of the patient.